LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 99

Search options

  1. Article ; Online: Mental Effects of Excess Parathyroid Hormone in Hemodialysis Patients: A Possible Role for Parathyroid 2 Hormone Receptor?

    Diskin, James / Diskin, Charles J

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

    2019  Volume 24, Issue 3, Page(s) 285–289

    Abstract: Depression as measured by the kidney disease quality of life (KDQOL) form is known to be an independent risk factor for mortality dialysis patients. Excess parathyroid hormone (PTH) has long been associated with neuropsychiatric disturbances. Those ... ...

    Abstract Depression as measured by the kidney disease quality of life (KDQOL) form is known to be an independent risk factor for mortality dialysis patients. Excess parathyroid hormone (PTH) has long been associated with neuropsychiatric disturbances. Those psychiatric complications are currently attributed to hypercalcemia with very little evidence; however, with the discovery of the parathyroid hormone 2 receptor (PTH2R) in the brain which can be activated by PTH, PTH2R might indicate a direct effect of PTH. As secondary and tertiary hyperparathyroidism is common in dialysis patients where the serum calcium is low or normal, we chose to investigate a possible relationship between PTH levels and depression in dialysis patients. This was a matched pair observational study with 10 patients with intact PTH values above 1000 pg/mL who were matched with 10 patients who had PTH values less than 400 pg/mL for the presence of diabetes, years on dialysis, duration of dialysis time, Kt/V, hemoglobin, and 25 OH vitamin D levels, as well as intravenous iron and erythropoietin administration. The Kidney Disease Quality of Life questionnaire (KDQOL-36) scores and patient Health Questionnaire scores were analyzed during that time. All variables underwent tests for normality and matched pair t-test. All subscales of the KDQOL-36 were worse in the high PTH group with the effect on daily life reaching P = 0.01 and the burden of disease and symptoms both reaching P = 0.02. PTH and PTH2R may be appropriate targets for investigations to improve the quality of life in hemodialysis patients.
    MeSH term(s) Correlation of Data ; Cost of Illness ; Depression/diagnosis ; Depression/etiology ; Depression/metabolism ; Duration of Therapy ; Female ; Humans ; Hyperparathyroidism, Secondary/diagnosis ; Hyperparathyroidism, Secondary/etiology ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/metabolism ; Kidney Failure, Chronic/psychology ; Kidney Failure, Chronic/therapy ; Male ; Matched-Pair Analysis ; Middle Aged ; Parathyroid Hormone/blood ; Quality of Life ; Receptor, Parathyroid Hormone, Type 2/metabolism ; Renal Dialysis/methods ; United States/epidemiology
    Chemical Substances Parathyroid Hormone ; Receptor, Parathyroid Hormone, Type 2
    Language English
    Publishing date 2019-09-11
    Publishing country Australia
    Document type Journal Article ; Observational Study
    ZDB-ID 2119809-3
    ISSN 1744-9987 ; 1091-6660 ; 1744-9979
    ISSN (online) 1744-9987
    ISSN 1091-6660 ; 1744-9979
    DOI 10.1111/1744-9987.13429
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: How effective is rescue therapeutic plasma exchange in treatment of SARS-Coronavirus-2?

    Diskin, Charles J / Maldonado, Ricardo / Leon, Jose / Dansby, Linda M / Carter, Thomas B / Radcliff, Lautrec / Diskin, Charles D

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

    2022  

    Abstract: Introduction: After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS-Coronoavirus-2, we analyzed its efficacy in patients who had failed all other known therapies.: Methods: This was a prospective ... ...

    Abstract Introduction: After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS-Coronoavirus-2, we analyzed its efficacy in patients who had failed all other known therapies.
    Methods: This was a prospective observational study of 42 patients with SARS-Coronoavirus-2 who had failed conventional therapy and were treated with therapeutic plasma exchange. Pre- and postexchange clinical and laboratory parameters were monitored. The patients were then also compared with a group of 147 patients with SARS-Coronoavirus-2 who were referred for stage 3 acute renal failure and dialysis from SARS-Coronoavirus-2.
    Results: After therapeutic plasma exchange, there were significant improvements in some clinical parameters but mortality remained high; although better than the renal failure group (43.9% vs. 50.7%, p = 0.004).
    Conclusion: SARS-CoV-2 patients who failed all other therapies had significant mortality with therapeutic plasma exchange; however, their survival was better than SARS-CoV-2 patients with stage 3 acute renal failure.
    Language English
    Publishing date 2022-05-01
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 2119809-3
    ISSN 1744-9987 ; 1091-6660 ; 1744-9979
    ISSN (online) 1744-9987
    ISSN 1091-6660 ; 1744-9979
    DOI 10.1111/1744-9987.13862
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Use of the Fractional Excretion of Urea in an Azotemic Nonoliguric State: Type 1 Cardiorenal Syndrome.

    Diskin, James B / Walker, Christopher Brandon / Oberle, Michael D / Diskin, Charles J

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

    2018  Volume 22, Issue 4, Page(s) 319–324

    Abstract: The fractional excretion of urea is a useful tool to evaluate renal function in oliguric states; however, it remains unexplored in nonoliguric states. We evaluated its use to predict responses in patients with type 1 cardiorenal syndrome. This was a ... ...

    Abstract The fractional excretion of urea is a useful tool to evaluate renal function in oliguric states; however, it remains unexplored in nonoliguric states. We evaluated its use to predict responses in patients with type 1 cardiorenal syndrome. This was a prospective observational study of 116 patients with type 1 cardiorenal syndrome referred over a 4-year period. Fractional excretion of urea and sodium, ejection fraction, mean arterial pressure, age, sex, diabetes, brain natriuretic peptide (BNP), serum sodium and blood urea nitrogen were analyzed for effects upon serum creatinine and survival. Improvement of renal function correlated most significantly with FeUrea (P = 0.00001) followed by the FeNa (P = 0.005) but no other variable studied reached significance. Survival was best predicted by improvement of the serum creatinine at 24 h (P = 0.005) and 7 days after all inotropes were stopped (P = 0.001). A limitation of this study is that it cannot be extrapolated to all cardiorenal syndrome patients other than type 1. Also, the study was not randomized and those with potentially worse disease have had worse outcomes due merely to worse underlying disease. The success of the FeUrea may possibly be related to interference of dobutamine on creatinine levels. Despite being a nonoliguric state, the FeUrea appears to provide insight to those patients with type 1 cardiorenal syndrome whose renal function (as measured by serum creatinine) and survival might improve.
    MeSH term(s) Aged ; Aged, 80 and over ; Azotemia/physiopathology ; Blood Urea Nitrogen ; Cardio-Renal Syndrome/drug therapy ; Cardio-Renal Syndrome/physiopathology ; Cardiotonic Agents/administration & dosage ; Creatinine/blood ; Dobutamine/administration & dosage ; Female ; Humans ; Kidney Function Tests ; Male ; Middle Aged ; Prospective Studies ; Sodium/blood ; Survival ; Urea/metabolism
    Chemical Substances Cardiotonic Agents ; Dobutamine (3S12J47372) ; Urea (8W8T17847W) ; Sodium (9NEZ333N27) ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2018-01-26
    Publishing country Australia
    Document type Journal Article ; Observational Study
    ZDB-ID 2119809-3
    ISSN 1744-9987 ; 1091-6660 ; 1744-9979
    ISSN (online) 1744-9987
    ISSN 1091-6660 ; 1744-9979
    DOI 10.1111/1744-9987.12661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Towards erythropoietin equations that estimate oxygen delivery rather than static hemoglobin targets.

    Diskin, Charles J

    Nephron. Clinical practice

    2012  Volume 120, Issue 1, Page(s) c48–53; discussion c53

    Abstract: Although we have known since the 19th century that oxygen tension affects erythrocyte production, we have only recently begun to understand many subtleties of erythropoietin physiology. The unanticipated increase in mortality associated with ... ...

    Abstract Although we have known since the 19th century that oxygen tension affects erythrocyte production, we have only recently begun to understand many subtleties of erythropoietin physiology. The unanticipated increase in mortality associated with erythropoietin use found in recent randomized studies is prompting a reassessment of static hemoglobin targets. Hemoglobin levels in dialysis patients do not correlate with endogenous erythropoietin production and may be related to differences in oxygen delivery resulting from shifts in the oxygen-hemoglobin dissociation curve. The time may have arrived to develop more physiologic targets such as oxygen delivery that would mimic the natural response to hypoxia. There are several equations that already exist that can compensate for the effects of the concentration of inorganic and organic phosphates as well as pH, carbon dioxide, and temperature on the delivery of oxygen. However, since the shape and dispersion of the oxygen-hemoglobin dissociation curve may actually change in different disease states, more work is needed.
    MeSH term(s) Algorithms ; Blood Transfusion ; Carbon Dioxide/blood ; Epoetin Alfa ; Erythropoiesis/drug effects ; Erythropoiesis/physiology ; Erythropoietin/administration & dosage ; Erythropoietin/adverse effects ; Erythropoietin/therapeutic use ; Feedback, Physiological ; Hemoglobins/analysis ; Humans ; Hydrogen-Ion Concentration ; Hypoxia/blood ; Hypoxia/physiopathology ; Hypoxia-Inducible Factor 1/physiology ; Models, Biological ; Oxygen/blood ; Oxyhemoglobins/metabolism ; Patient Care Planning ; Phosphates/blood ; Randomized Controlled Trials as Topic ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/therapeutic use
    Chemical Substances Hemoglobins ; Hypoxia-Inducible Factor 1 ; Oxyhemoglobins ; Phosphates ; Recombinant Proteins ; Erythropoietin (11096-26-7) ; Carbon Dioxide (142M471B3J) ; Epoetin Alfa (64FS3BFH5W) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2012
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 207121-6
    ISSN 1660-2110 ; 1423-0186 ; 2235-3186 ; 1660-8151 ; 0028-2766
    ISSN (online) 1660-2110 ; 1423-0186 ; 2235-3186
    ISSN 1660-8151 ; 0028-2766
    DOI 10.1159/000334627
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Lessons from single cell organisms: insights into the antimicrobial and toxic effects of peritoneal dialysate bases.

    Diskin, Charles J

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

    2010  Volume 14, Issue 2, Page(s) 127–135

    Abstract: Although it was first described over a quarter of a century ago, the mechanisms behind the antimicrobial activity of fresh peritoneal dialysate have been poorly understood. Recent insight into the biochemistry appears to suggest that at least part of the ...

    Abstract Although it was first described over a quarter of a century ago, the mechanisms behind the antimicrobial activity of fresh peritoneal dialysate have been poorly understood. Recent insight into the biochemistry appears to suggest that at least part of the effect resides in the salts of the carboxylic acids. An understanding of the metabolic pathways of both sensitive and resistant organisms has not only led to an understanding of the mechanisms of the antimicrobial effect, but also may have provided the insight for future studies to reduce toxicity to the peritoneal membrane. While our knowledge base in this area is still evolving, an improved understanding of the biochemical basis of both the antibacterial effect and toxicity of the salts of carboxylic acids in peritoneal dialysate can only prove useful.
    MeSH term(s) Animals ; Bacteria/metabolism ; Carboxylic Acids/chemistry ; Carboxylic Acids/metabolism ; Dialysis Solutions/chemistry ; Dialysis Solutions/metabolism ; Humans ; Peritoneal Dialysis/methods ; Peritoneum/chemistry ; Peritoneum/metabolism
    Chemical Substances Carboxylic Acids ; Dialysis Solutions
    Language English
    Publishing date 2010-04
    Publishing country Australia
    Document type Journal Article ; Review
    ZDB-ID 2119809-3
    ISSN 1744-9987 ; 1091-6660 ; 1744-9979
    ISSN (online) 1744-9987
    ISSN 1091-6660 ; 1744-9979
    DOI 10.1111/j.1744-9987.2009.00745.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Novel insights into the pathobiology of the vascular access - do they translate into improved care?

    Diskin, Charles J

    Blood purification

    2010  Volume 29, Issue 2, Page(s) 216–229

    Abstract: While recent developments have allowed greater insight into the vascular pathobiology and intimal hyperplasia, very few of these advances have led to improved clinical care of hemodialysis vascular accesses. Indeed the most common procedure for the ... ...

    Abstract While recent developments have allowed greater insight into the vascular pathobiology and intimal hyperplasia, very few of these advances have led to improved clinical care of hemodialysis vascular accesses. Indeed the most common procedure for the treatment of access stenosis and thrombosis is the same model for the creation and study of intimal hyperplasia. The evolution of our understanding of vascular thrombosis is reviewed with a current concept that includes a dynamic interplay of the biophysics, chemistry and biology of the blood vessel with the blood and its constituents. Implications for possible future interventions based on these novel concepts are offered, and the significance of improving our understanding of the pathobiology is emphasized.
    MeSH term(s) Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Arteriovenous Shunt, Surgical/adverse effects ; Calcium Channel Blockers/therapeutic use ; Catheters, Indwelling/adverse effects ; Cell Movement/drug effects ; Constriction, Pathologic ; Drug-Eluting Stents ; Endothelium, Vascular/injuries ; Epoprostenol/physiology ; Equipment Failure ; Forecasting ; Hemorheology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hyperplasia ; Models, Cardiovascular ; Nitric Oxide/physiology ; Pentoxifylline/therapeutic use ; Randomized Controlled Trials as Topic ; Renal Dialysis/methods ; Sepsis/etiology ; Sepsis/prevention & control ; Thrombosis/etiology ; Thrombosis/physiopathology ; Thrombosis/prevention & control ; Tunica Intima/pathology ; Vasodilation
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; Anticoagulants ; Calcium Channel Blockers ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Nitric Oxide (31C4KY9ESH) ; Epoprostenol (DCR9Z582X0) ; Pentoxifylline (SD6QCT3TSU)
    Language English
    Publishing date 2010
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 605548-5
    ISSN 1421-9735 ; 0253-5068
    ISSN (online) 1421-9735
    ISSN 0253-5068
    DOI 10.1159/000245650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The promise of pentoxifylline and interference with the renin-angiotensin system in diabetic nephropathy.

    Diskin, Charles J

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2009  Volume 53, Issue 2, Page(s) 355; author reply 355–6

    MeSH term(s) Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Diabetic Nephropathies/drug therapy ; Diabetic Nephropathies/urine ; Drug Therapy, Combination ; Humans ; Pentoxifylline/administration & dosage
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Pentoxifylline (SD6QCT3TSU)
    Language English
    Publishing date 2009-02
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2008.09.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Standards and precision of thought: what might Galbraith say?

    Diskin, Charles J

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2008  Volume 51, Issue 1, Page(s) 161–2; author reply 162–3

    MeSH term(s) Calibration/standards ; Chronic Disease ; Humans ; Kidney Diseases/diagnosis ; Kidney Diseases/urine ; Practice Guidelines as Topic ; Reference Standards ; Urinalysis/standards
    Language English
    Publishing date 2008-01
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2007.09.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Erythropoietin, haemoglobin, heart failure, and mortality.

    Diskin, Charles J

    European heart journal

    2008  Volume 29, Issue 21, Page(s) 2695; author reply 2695–6

    MeSH term(s) Biomarkers/blood ; Erythropoietin/blood ; Heart Failure/mortality ; Hemoglobins/metabolism ; Humans
    Chemical Substances Biomarkers ; Hemoglobins ; Erythropoietin (11096-26-7)
    Language English
    Publishing date 2008-11
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehn399
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The role of the nephrologist in the treatment of lupus nephritis.

    Diskin, Charles J

    Nature clinical practice. Nephrology

    2007  Volume 3, Issue 8, Page(s) E1

    MeSH term(s) Humans ; Lupus Nephritis/therapy ; Nephrology
    Language English
    Publishing date 2007-08
    Publishing country England
    Document type Comment ; Journal Article
    ZDB-ID 2228557-X
    ISSN 1745-8331 ; 1745-8323
    ISSN (online) 1745-8331
    ISSN 1745-8323
    DOI 10.1038/ncpneph0552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top